3 results
Radiolabeled bevacizumab as a tracer of VEGF expression in patients with colorectal liver metastases
Evaluation of tumor localization of In-111 labeled bevacizumab and possible correlation with VEGF expression in patients with colorectal liver metastases.
Approved WMOCompleted
Primary Objective: Is the detection chance of the bladder influenced by the angle in which the ultrasound sensor is fixated? Secondary Objective Can the URIKA Bladder Monitor (UBM) be used to predict the point where the BladderScan reaches the…
Approved WMOCompleted
PART B (FL phase IIb *PARADIGME*):Primary objective:Randomised section of Part B- To evaluate the efficacy of the *40/15* dose regimen (40 mg lilotomab / 15 MBq/kg Betalutin) compared with *100/20* dose regimen (100 mg/m2 lilotomab/ 20 MBq/kg…